PMID: 2107213Jan 1, 1990Paper

Detection of lupus like anticoagulant: current laboratory practice in the United Kingdom. The Lupus Anticoagulant Working Party

Journal of Clinical Pathology

Abstract

Various tests have been advocated for the detection of lupus like anticoagulants (LA) and related antiphospholipid antibodies, but there is no agreement on the most appropriate laboratory approach. Two hundred and fifty five of 433 hospital centres in the United Kingdom responded to a questionnaire. Many different tests were reported to be in use for screening for LA with considerable variation in plasma preparation, choice of reagent, and methodological details. Three freeze dried plasmas were subsequently assessed for the presence of LA by 183 laboratories. While 92% correctly identified a strong inhibitor and 91% a negative control, only 65% correctly identified a weak inhibitor. Pronounced variations in the suitability of commonly used reagents in the activated partial thromboplastin time test (APTT) were noted and important methodological features were identified in the kaolin clotting time, dilute thromboplastin time, and dilute Russell's viper venom time tests. It is concluded that careful plasma preparation, with avoidance of platelet contamination, use of a suitable test in addition to the APTT, and attention to methodological detail are essential for the reliable identification of LA, a clinically important inhibitor.

References

Sep 1, 1978·British Journal of Haematology·T ExnerH Kronenberg
Jan 22, 1988·JAMA : the Journal of the American Medical Association·D A TriplettC A Orr
Oct 15, 1983·British Medical Journal·G R Hughes

❮ Previous
Next ❯

Citations

Feb 1, 1995·American Journal of Hematology·N J FreemanA Carvalho
Jan 1, 1992·International Journal of Clinical & Laboratory Research·C LegnaniS Coccheri
Apr 1, 1997·Fertility and Sterility·E GevaJ B Lessing
Jun 1, 1993·Australian and New Zealand Journal of Medicine·M A Kirkland, A S Gallus
May 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·M Greaves
Mar 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·J SussmanG A Davies-Jones
Oct 28, 2004·Thrombosis Research·Ronald H W M Derksen, Philip G de Groot
Dec 1, 1991·Blood Reviews·A Gray, J Morgan
May 17, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Silvia S Pierangeli, E Nigel Harris
Jan 1, 1992·Pathology·A I O'NeillJ Des Parkin
Apr 25, 2007·Critical Reviews in Clinical Laboratory Sciences·P G VlachoyiannopoulosP Tsiligros
Jan 1, 1991·Journal of Clinical Pathology·M D CreaghM Greaves
Jun 1, 1994·Journal of Clinical Pathology·A M RooneyS J Machin
Jun 4, 2005·European Journal of Nutrition·Peter J AggettHans Verhagen
Jul 1, 2009·Journal of Laboratory Physicians·Ebele J IkekpeazuUche Ifejimalu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.